Keywords: pdt, snet2, study, data, phase, i/ii, results

PDT's SnET2 study data

Article | 18 December 1995

Print This

- Phase I/II results for PDT's SnET2 (ethyl etiopurpurin) show the drug to be active against certain skin cancers and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in